To evaluate the efficacy of the NV200 on reducing Mycobacterium tuberculosis.
The NV200 unit was placed inside a 68 litre plastic enclosure. The plastic enclosure and test set up was placed inside a biosafety cabinet. Clinical isolate of Mycobacterium tuberculosis was aseptically transferred into a sterile mycobacteria growth indicator tube (MGIT) and Lowenstein-Jensen (LJ) medium.
The air sample collected from the test after being exposed to the NV200 showed no growth of Mycobacterium tuberculosis. This shows that the device has effectively rendered all airborne Mycobacterium tuberculosis non-viable.
About Us
Novaerus is on a mission to reduce indoor airborne pollutants that lead to infection, allergies, asthma, and odour.
The patented plasma nanotechnology used in Novaerus portable devices was invented in Ireland in 2006.
Novaerus Devices
Stay Connected to Novaerus
To keep up to date with all developments and for the latest research and scientifically proven results please follow us on LinkedIn, Facebook and Youtube.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.